货号:A621408
同义名:
CFTR Inhibitor; Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor IV
PPQ-102是一种强效、独立于电压的 CFTR 抑制剂,可完全抑制 CFTR 氯离子电流,IC50 约为 90 nM,可有效防止多囊肾病囊肿扩大。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | CFTR ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ataluren | ✔ | 98% | |||||||||||||||||
| Lumacaftor |
++++
F508del-CFTR, EC50: 0.1 μM |
98% | |||||||||||||||||
| CFTR(inh)-172 |
+++
CFTR, Ki: 300 nM |
99%+ | |||||||||||||||||
| GlyH-101 |
+
CFTR, Ki: 4.3 μM |
99%+ | |||||||||||||||||
| IOWH-032 |
++
CFTR, IC50: 1.01 μM |
99%+ | |||||||||||||||||
| Tezacaftor | ✔ | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | CFTR is a chloride channel, that controls ion and water secretion and absorption in epithelial tissues. CFTR protein dysfunction leads to abnormal ion transport across the airway epithelium[3]. PPQ2 as a small molecule CFTR inhibitor that completely inhibited CFRR chloride current with IC50 value of 90 nM[4]. In vitro, PPQ-102 at the dose of 10µM inhibited CFTR almost 100% in (nonpermeabilized) human intestinal (T84) and bronchial cells following maximal CFTR activation by forskolin and IBMX. However, PPQ-102 did not inhibit calcium-activated chloride channels or cellular cAMP production[4]. PPQ-102 also inhibited the volume-regulated anion channel (VRAC) conductance with IC50 value of 20μM in HEK293 cells[5]. Treatment of NCI-H292 cells with 10μM PPQ-102 induced a two-fold increase in VEGF-A synthesis[3]. In the presence of NADPH, PPQ-102 lost in hepatic microsomes about 60% within 30min. No loss of PPQ-102 was seen in the absence of NADPH. In vivo, PPQ-102 was undetectable in serum, kidney and urine at 30-60 min after intravenous administration of 300μg PPQ-102 by LC/MS assay with sensitivity better than 100nM[6]. |
| 作用机制 | PPQ-102 inhibits CFTR by an altered channel gating mechanism, with stabilization of the channel closed state[4]. |
| Concentration | Treated Time | Description | References | |
| NPTr cells | 30 µM | 2 hours | Inhibition of VRAC activity, reducing CDT-induced apoptosis in NPTr cells | Virulence. 2023 Dec;14(1):2287339 |
| CFBE41o- WT cells | 0.1, 1, 5, 10, 20, 30 µM | 48 hours | To evaluate the anti-SARS-CoV-2 activity of PPQ-102. Results showed that PPQ-102 inhibited SARS-CoV-2 replication by nearly 100% at 30 μM, with an IC50 of 15.92 μM. | Cells. 2023 Feb 28;12(5):776 |
| HEK-293 cells | 10 µM and 30 µM | 5 minutes | Test the inhibitory effect of PPQ-102 on VRAC/LRRC8-mediated chloride conductance, with an IC50 value of 19.6±1.5 μM | Front Pharmacol. 2017 May 31;8:328 |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Polycystic kidney disease model | Added to culture medium | 0.5 µM, 2.5 µM, 5 µM | Medium replaced every 12 hours for 4 days | Evaluating PPQ-102 inhibition of cyst formation, 0.5 μM PPQ-102 inhibited cyst formation by ~60%, and 2.5 μM and 5 μM PPQ-102 nearly completely inhibited cyst formation. | J Med Chem. 2009 Oct 22;52(20):6447-55 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.28mL 0.46mL 0.23mL |
11.40mL 2.28mL 1.14mL |
22.81mL 4.56mL 2.28mL |
|
| CAS号 | 931706-15-9 |
| 分子式 | C26H22N4O3 |
| 分子量 | 438.48 |
| SMILES Code | CC1=CC=C(C2C3=C(C4=C(N3C5=C(N2)C=CC=C5)C6=CC=CC=C6)N(C)C(N(C4=O)C)=O)O1 |
| MDL No. | MFCD14824240 |
| 别名 | CFTR Inhibitor; Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor IV; CFTR Inhibitor IV |
| 运输 | 蓝冰 |
| InChI Key | MNOOVRNGPIWJDI-UHFFFAOYSA-N |
| Pubchem ID | 16016583 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 50 mg/mL(114.03 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1